Becton Dickinson Stock - Weekly review and sector snapshot for medtech
19.06.2026 - 22:58:29 | ad-hoc-news.de
Edited by ad hoc news Sector & Peer-Group Desk. Verified prior to publication on 06/19/2026, 20:45 UTC. Details in the imprint.
Becton Dickinson (US0758871091) is ending the week with a steady share price profile in a mixed US medtech sector. The stock remains a Standard & Poor's 500 index component alongside peers such as Medtronic and Abbott Laboratories, according to exchange data and index compilers.
Background and price data on Becton Dickinson stock
Key news, regulatory filings and chart data on Becton Dickinson stock can be found bundled on the ad hoc news topic page and on the company's own Investor Relations site.
How Becton Dickinson ended the week
On the New York Stock Exchange, Becton, Dickinson and Company shares most recently closed at $143.99 on 06/18/2026, according to price data from MarketBeat, which tracks the stock under the ticker BDX. MarketBeat quote overview for BDX
That closing level left the stock roughly unchanged on the day and near the lower half of its 52-week range, which spans approximately $130 to $260 based on recent quote information from public market data providers. NYSE listing data for BDX
Sector comparison for the week
Compared with larger medtech peers, Becton Dickinson has shown a more muted share-price pattern in recent sessions. By contrast, MarketBeat data show higher volatility in some diagnostics and life-science tool stocks over the same period. MarketBeat peer snapshot for Medtronic
The broader health care equipment and supplies group inside the Standard & Poor's 500 index has been trading sideways, according to index-level summaries from major US exchanges, which tends to dampen momentum for diversified device makers such as Becton Dickinson.
What the company sells
Becton Dickinson generates revenue mainly from medical devices, diagnostic systems and biosciences products. Flagship offerings include its BD Alaris infusion pumps, BD Vacutainer blood collection systems and BD Veritor rapid diagnostic tests, according to company materials.
Where the stock trades today
The shares of Becton, Dickinson and Company (US0758871091) trade on the New York Stock Exchange at $143.99 as of 06/18/2026, 16:00 Eastern Time.
Key facts on Becton Dickinson stock
- Company: Becton, Dickinson and Company
- ISIN: US0758871091
- WKN: 857209
- Ticker: BDX
- Venue: NYSE
- Price (as of 06/18/2026, 16:00 Eastern Time): 143.99 USD
- Market cap: approximately 41,0 billion USD (as of 06/18/2026)
- Sector / Industry: Health Care - Medical Instruments & Supplies
- Index membership: Standard & Poor's 500 index
- Next earnings date: not officially scheduled
This article was AI-assisted and editorially reviewed. Price and company data without warranty; prices and dates may change at short notice. No investment advice, no buy or sell recommendation. Trading securities involves risk up to total loss of capital.
